Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income	$ 20	$ 40
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	27	28
Stock-based compensation expense	34	28
Deferred income taxes	12	7
Loss on Blue Chip Swap	2	0
Changes in assets and liabilities:
Receivables	(25)	23
Inventories	(3)	1
Current payables and accrued expenses	(30)	(41)
Deferred revenue	(6)	41
Other assets and liabilities	(4)	(18)
Net cash provided by operating activities	27	109
Investing activities
Expenditures for property and equipment	(6)	(4)
Other investing activities, net	(2)	0
Net cash used in investing activities	(8)	(4)
Financing activities
Repurchases of common stock	(124)	(84)
Payments of finance leases	(20)	(20)
Other financing activities, net	(6)	(7)
Net cash used in financing activities	(150)	(111)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(17)	(10)
Decrease in cash, cash equivalents and restricted cash	(148)	(16)
Cash, cash equivalents and restricted cash at beginning of period	486	571
Cash, cash equivalents and restricted cash at end of period	338	555
Supplemental cash flow disclosure:
Assets acquired under operating lease	0	1
Assets acquired under finance lease	11	30
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	337
Restricted cash	1
Total cash, cash equivalents and restricted cash	$ 338	$ 555